Autophagy inhibition improves anti-cancer drugs
via
FOXO3a activation
Oncotarget
.
2018 May 22;9(39):25384-25385.
doi: 10.18632/oncotarget.25366.
Authors
Brent E Fitzwalter
1
,
Andrew Thorburn
1
Affiliation
1
Andrew Thorburn: Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA.
PMID:
29875995
PMCID:
PMC5986638
DOI:
10.18632/oncotarget.25366
No abstract available
Keywords:
Autophagy; CRISPR/Cas9; FOXO3a; MDM2; PUMA; apoptosis.
Publication types
Editorial
Grants and funding
T32 GM007635/GM/NIGMS NIH HHS/United States